- زرگری، ع. 1375. گیاهان دارویی. جلد اول، انتشارات و چاپ دانشگاه تهران، 432 صفحه.
- Ahaneku, J.E., Nwosu, C.M. and Farotimi, A., 2001. Lipid and lipoprotein cardiovascular risk factor responses to episodic academic stress. Journal of Health Science, 47, 3: 323-326.
- Andrea, Y.A. and Plate, J.A.G., 2002. Cholesterol-lowering effect of extruded amaranth (Amaranthus caudatus L.). Food Chemistry, 76: 1-6.
- Borradaile, N.M., Dreu, L.E., Barrett, P.H.R. and Huff, M.W., 2002. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradtion independent of reduced microsomal cholesteryl esters. Journal of Lipid Research, 43:1544-1554.
- Bhatia, A.L. and Jain, M., 2003. Amaranthus paniculatus (Lim.) improves learning after radiation stress. Journal of Ethnopharmacology, 85: 73-79.
- Chekanov, V.S., 2003. Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Medical science monitor, 9(8): 302-309.
- Danz, R.A. and Lupton, J.R., 1992. Physiology effects of dietary amaranth (Amaranthus cruentus) on rats. Cereal Foods World, 37(7): 489-494.
- Erdemoglu, N., Kupeli, E. and Yesilada, E., 2003. Anti-inflammatory and antinociceptive assessment of plants used as remedy in Turkish folk medicine. Journal of Ethnopharmacology, 89: 123 – 129.
- Grundy, S.M., Pasternak, R. and Greenland, P., 1999. Assessment of cardiovascular risk by use of multiple-risk professionals from the AmericanCollege of Cardiology. Journal of the AmericanCollege of Cardiology, 34: 1348-59.
- Parmley, W.W., 1997. Nonlipoprotein risk factors for coronary heart disease: evaluation and management. American Journal of Medicine, 102: 7-14.
- Pergola, C., Rossi, A., Dugo, P., Cuzzocrea, S. and Sautebin, L., 2006. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Biology and Chemistry, 15: 30-39.
- Qureshi, A.A., Qureshi, N., Wright, J.J.K., Shen, Z., Kramer, G., Gapor, A., Chong, Y.H. and Bradlow, B.A., 1991. Lowering of serum cholesterol in hyperchlesterolemic humans by tocotrienols (palmvitee). American Journal of Clinical Nutrition, 53:1021-1026.
- Rasouli, M., Kiasari. M.A. and Mokhberi, V., 2006. The ratio apoB/apoA, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clinical Chemistry and Laboratory Medicine, 44(8): 1015-1021.
- Thakur, N., Hayashi, T. and Iguchi, A., 2001. HMG-COA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxidase. American Journal Physiology, 281: 75-83.
- Walldius, G. and Jungner, I., 2004. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine, 255:188-205.
- Walldius, G., Jungner, I., Holme, I., Aastveit, A.H., Kolar, W. and Steiner, E., 2001. High apolipoprotein B, low apolipoprotein A-I and improvement in the prediction of fatal myocardial infarction: aprospective study. Lancet, 358: 2026-2033.
- Yusuf, S., Hawken, S., Ounpuu, S., Dans, T. and Avezum, A., 2004. Effect of potentially modifiable risk factors assoiated with myocardial infarction in 52 countries: case control study. Lancet, 364: 937-952.
- Zou, Y., Lu, Y. and Wei, D., 2005. Hypercholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet. Journal of Agricultural and Food Chemistry, 53: 2462-2466
)